Document:

Exhibit 10.3

 

NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH
THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THESE
SECURITIES HAVE BEEN SOLD IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.

 

HOME BISTRO, INC.

 

15% CONVERTIBLE NOTE

 

	Issuance Date: May 24, 2022	Original Principal Amount: $182,926.83
	Note No. HBIS-2	Consideration Paid at Close: $164,634.15

 

FOR VALUE RECEIVED, Home
Bistro, Inc., a Nevada corporation with a par value of $0.001 per common share (“Par Value”) (the “Company”),
hereby promises to pay to the order of GS Capital Partners, LLC, a Nevada limited liability company, or registered assigns (the “Holder”)
the amount set out above as the Original Principal Amount (this “Note”) (as reduced pursuant to the terms hereof pursuant
to redemption, conversion or otherwise, the “Principal”) when due, whether upon the Maturity Date (as defined below),
acceleration, redemption or otherwise (in each case in accordance with the terms hereof) and to pay interest (“Interest”)
on any outstanding Principal at the rate of fifteen percent (15%) per annum from the date hereof (the “Issuance Date”)
until the same becomes due and payable, upon the Maturity Date or acceleration, conversion, redemption or otherwise (in each case in accordance
with the terms hereof).

 

The Original Principal Amount
is $182,926.83 (one hundred eighty-two thousand nine hundred twenty-six dollars and eighty-three cents) plus accrued and unpaid interest
and any other fees. The Consideration is $164,634.15 (one hundred sixty-four thousand six hundred thirty-four dollars and fifteen cents)
payable by wire transfer (there exists a $18,292.68 prorated original issue discount (the “OID”)). The Holder
shall pay $164,634.15 of Consideration upon closing of this Note pursuant to a disbursement authorization dated as of the Issuance Date
and signed by the Company.

 

(1)
GENERAL TERMS.

 

(a) Payment of Principal.
The maturity date shall be May 24, 2023 (the “Maturity Date”), and is the date upon which the Principal (which includes
the OID) and interest and any accrued and unpaid interest and other fees, shall be due and payable. Notwithstanding the foregoing, this
Note shall be due and payable on such earlier date as this Note is required to be repaid as provided hereinbelow.

 

(b) Interest Calculations.
Interest shall be calculated on the basis of a 360-day year, consisting of twelve 30 calendar day periods, and shall accrue daily commencing
on the Issuance Date until payment in full of the outstanding principal, together with all accrued and unpaid interest, liquidated damages
and other amounts which may become due hereunder, has been made. Interest hereunder will be paid to the Person in whose name this Note
is registered on the records of the Company regarding registration and transfers of this Note on (i) the Maturity Date and (ii) any other
date on which principal is paid or payable under this Note, on the principal amount so paid or payable.

 

(c) Security. This
Note shall not be secured by any collateral or any assets pledged to the Holder.

 

     

     

    

 

(2) DEFINITIONS.
For the purposes hereof, in addition to the terms defined elsewhere in this Note, (a) capitalized terms not otherwise defined herein
shall have the meanings set forth in the Purchase Agreement (as defined in this Note) and (b) the following terms shall have the
following meanings:

 

“Business Day”
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by
law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to
remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee” or any other similar
orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic
funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally are open for use by customers
on such day.

 

“Common Stock Equivalents”
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

 

“Conversion Amount”
means the portion of the Original Principal Amount and Interest to be converted, plus any penalties, redeemed or otherwise with respect
to which this determination is being made.

 

“Conversion Price”
means the per share conversion price into which Principal and Interest under this Note shall be convertible into shares of Common Stock
hereunder, which shall equal the lower of (i) 75% of the closing price of the Common Stock on the date of the investment, and (ii) 90%
of the lowest volume weighted average price for the Common Stock during the five (5) Trading Day
period ending on the latest complete Trading Day prior to the Conversion Date, provided, however, that if the Company consummates
an Uplist Offering (as defined in this Note) on or before the date that is one hundred and eighty (180) calendar days after the Issuance
Date, then the Conversion Price shall equal 75% of the offering price per share of Common Stock (or unit, if units are offered in the
Uplist Offering) at which the Uplist Offering is made (for the avoidance of doubt, if a unit includes more than one share of the Common
Stock in the Uplist Offering, the Conversion Price shall mean 75% of the unit price divided by the number of shares of Common Stock contained
in a unit). Unless otherwise adjusted pursuant to the terms of this Note, if the date of a respective conversion under this Note is prior
to the date of the Company’s consummation of an Uplist Offering, then the Conversion Price shall equal $0.345 per share.

 

“Person”
and “Persons” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust,
an unincorporated organization, any other entity and any governmental entity or any department or agency thereof.

 

“Purchase Agreement”
means the Securities Purchase Agreement, dated as of May 24, 2022, by and among the Company and the original Holders, as amended, modified
or supplemented from time to time in accordance with its terms.

 

“Trading Day”
means any day during which the principal market on which the Common Stock is traded shall be open for business, provided, however, that
if the Common Stock is not then listed or quoted on any Principal Market, then any calendar day

 

“Uplist Offering”
means an offering of Common Stock (or units consisting of Common Stock and warrants to purchase Common Stock) that will result in the
immediate listing for trading of the Common Stock on the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq
Global Select Market, the New York Stock Exchange, or any other national securities exchange (or any successors to any of the foregoing).

 

    2

     

    

 

(3) EVENTS
OF DEFAULT.

 

(a)
An “Event of Default”, wherever used herein, means any one of the following events (whatever the reason and whether
it shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court, or any
order, rule or regulation of any administrative or governmental body):

 

(i)
The Company’s failure to pay to the Holder any amount of Principal, Interest, or other amounts when and as due under this Note or
pursuant to the Purchase Agreement (including, without limitation, the Company’s failure to pay any amounts hereunder); and

 

(ii)
A Conversion Failure as defined in section 3(b)(ii)

 

(iii) The Company or any subsidiary of the Company shall commence, or there shall be commenced against the Company or any subsidiary of the
Company under any applicable bankruptcy or insolvency laws as now or hereafter in effect or any successor thereto, or the Company or any
subsidiary of the Company commences any other proceeding under any reorganization, arrangement, adjustment of debt, relief of debtors,
dissolution, insolvency or liquidation or similar law of any jurisdiction whether now or hereafter in effect relating to the Company or
any subsidiary of the Company or there is commenced against the Company or any subsidiary of the Company any such bankruptcy, insolvency
or other proceeding which remains undismissed for a period of 61 days; or the Company or any subsidiary of the Company is adjudicated
insolvent or bankrupt; or any order of relief or other order approving any such case or proceeding is entered; or the Company or any subsidiary
of the Company suffers any appointment of any custodian, private or court appointed receiver or the like for it or any substantial part
of its property which continues undischarged or unstayed for a period of sixty one (61) days; or the Company or any subsidiary of the
Company makes a general assignment for the benefit of creditors; or the Company or any subsidiary of the Company shall fail to pay, or
shall state that it is unable to pay, or shall be unable to pay, its debts generally as they become due; or the Company or any subsidiary
of the Company shall call a meeting of its creditors with a view to arranging a composition, adjustment or restructuring of its debts;
or the Company or any subsidiary of the Company shall by any act or failure to act expressly indicate its consent to, approval of or acquiescence
in any of the foregoing; or any corporate or other action is taken by the Company or any subsidiary of the Company for the purpose of
effecting any of the foregoing;

 

(iv)
The Company or any subsidiary of the Company shall default in any of its obligations under any other note or any mortgage, credit agreement
or other facility, indenture agreement, factoring agreement or other instrument under which there may be issued, or by which there may
be secured or evidenced any indebtedness for borrowed money or money due under any long term leasing or factoring arrangement of the Company
or any subsidiary of the Company in an amount exceeding $100,000, whether such indebtedness now exists or shall hereafter be created;

 

(v)
The Common Stock is suspended or delisted for trading on the principal market on which the Common Stock is then listed or quoted (including
but not limited to any tier of the OTC Markets, any tier of the NASDAQ Stock Market (including NASDAQ Capital Market), or the NYSE American,
or any successor to such markets);

 

(vi)
The Company loses its ability to deliver shares via “DWAC/FAST” electronic transfer;

 

(vii) The Company loses its status as “DTC Eligible”;

 

(viii) The Company shall
fail to comply with the reporting requirements of the 1934 Act and/or the Company shall cease to be subject to the reporting
requirements of the 1934 Act;

 

    3

     

    

 

(ix)
The Company shall fail to reserve and keep available out of its authorized Common Stock a number of shares equal to at least two (2) times
the full number of shares of Common Stock issuable upon conversion of all outstanding amounts under this Note;

 

(x)
The Company shall fail to meet all requirements to satisfy the availability of Rule 144 to the Holder or its assigns including but not
limited to timely fulfillment of its filing requirements as a fully-reporting issuer registered with the SEC, requirements for XBRL filings,
and requirements for disclosure of financial statements on its website;

 

(xi)
The failure by the Company to maintain any material intellectual property rights, personal, real property or other assets which are necessary
to conduct its business (whether now or in the future);

 

(xii) The Company breaches
any covenant, agreement, or other term or condition contained in the securities purchase agreement entered into between the Company
and the Holder on the Issuance Date (the “Purchase Agreement”), this Note, the Warrant (as defined in the Purchase
Agreement) (the “Warrant”), or in any agreement, statement or certificate given in writing pursuant hereto or in
connection herewith or therewith;

 

(xiii) Any representation
or warranty of the Company made in the Purchase Agreement, this Note, the Warrant, or in any agreement, statement or certificate
given in writing pursuant hereto or in connection herewith or therewith shall be false or misleading in any material respect when
made; and

 

(xiv) Any dissolution, liquidation, or winding up of Company or any substantial portion of its business.

 

(xv)
Unavailability of Rule 144. If, at any time on or after the date which is six (6) months after the Issue Date, the Holder is unable to
(i) obtain a standard “144 legal opinion letter” from an attorney reasonably acceptable to the Holder, the Holder’s
brokerage firm (and respective clearing firm), and the Company’s transfer agent in order to facilitate the Holder’s conversion
of any portion of the Note into free trading shares of the Company’s Common Stock pursuant to Rule 144, and (ii) thereupon deposit
such shares into the Holder’s brokerage account.

 

(xvi) OTC Markets
Designation. OTC Markets changes the Company’s designation to ‘No Information’ (Stop Sign), ‘Caveat
Emptor’ (Skull and Crossbones), or ‘OTC’, ‘Other OTC’ or ‘Grey Market’ (Exclamation Mark
Sign).

 

(b)
Upon the occurrence and during the continuation of any Event of Default, the Note shall become immediately due and payable and the Company
shall pay to the Holder, in full satisfaction of its obligations hereunder, an amount equal to 150% times the sum of (w) the then outstanding
principal amount of this Note plus (x) accrued and unpaid interest on the unpaid principal amount of this Note to the date of payment
(the “Mandatory Prepayment Date”) plus (y) Default Interest, if any, on the amounts referred to in clauses (w) and/or (x)
plus (z) any amounts owed to the Holder pursuant to Article IV hereof (the then outstanding principal amount of this Note to the date
of payment plus the amounts referred to in clauses (x), (y) and (z) shall collectively be known as the “Default Amount”) and
all other amounts payable hereunder shall immediately become due and payable, all without demand, presentment or notice, all of which
hereby are expressly waived, together with all costs, including, without limitation, legal fees and expenses, of collection, and the Holder
shall be entitled to exercise all other rights and remedies available at law or in equity. Upon an Event of Default, at the option of
the Holder the Conversion Price shall equal 90% of the lowest volume weighted average price for
the Common Stock during the five (5) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date.

 

If the Company fails to pay the Default Amount
within ten (10) business days of written notice that such amount is due and payable, then the Holder shall have the right at any time,
to convert the balance owed pursuant to the note including the Default Amount into shares of common stock of the Company as set forth
herein.

 

    4

     

    

 

(4) CONVERSION
OF NOTE. This Note shall be convertible into shares of the Company’s Common Stock, on the terms and conditions set forth
in this Section 4.

 

(a)
(a) Conversion Right. The Holder shall have the right at any time on or following the earlier of (i) the date that an Event of
Default (as defined in this Note) occurs or (ii) the date that the Uplist Offering is consummated, to convert all or any portion of the
then outstanding and unpaid Principal and Interest into fully paid and non-assessable shares of Common Stock, as such Common Stock exists
on the Issuance Date, or any shares of capital stock or other securities of the Company into which such Common Stock shall hereafter be
changed or reclassified, at the Conversion Price (as defined below) determined as provided herein (a “Conversion”).
The number of shares of Common Stock issuable upon conversion of any Conversion Amount pursuant to this Section 4(a) shall be equal to
the quotient of dividing the Conversion Amount by the Conversion Price. The Company shall not issue any fraction of a share of Common
Stock upon any conversion. If the issuance would result in the issuance of a fraction of a share of Common Stock, the Company shall round
such fraction of a share of Common Stock up to the nearest whole share. The Company shall pay any and all transfer agent fees, legal fees,
costs and any other fees or costs that may be incurred or charged in connection with the issuance of shares of the Company’s Common
Stock to the Holder arising out of or relating to the conversion of this Note.

 

(b)
Mechanics of Conversion.

 

(i)
Optional Conversion. To convert any Conversion Amount into shares of Common Stock on any date that the Holder is permitted to effectuate
a conversion pursuant to the terms of this Note (a “Conversion Date”), the Holder shall (A) transmit by email, facsimile,
or other form of delivery, on or prior to 11:59 p.m., New York, NY Time, on such date, a copy of an executed notice of conversion in the
form attached hereto as Exhibit A (the “Conversion Notice”) to the Company. On or before the third (3rd)
Business Day following the date of Holder’s transmission of a Conversion Notice (the “Share Delivery Date”),
the Company shall (A) if legends are not required to be placed on certificates of Common Stock pursuant to the then existing provisions
of Rule 144 of the Securities Act of 1933 (“Rule 144”) or any other applicable exemption or registration and provided that
the Transfer Agent is participating in the Depository Trust Company’s (“DTC”) Fast Automated Securities Transfer
Program and the Holder provides full and complete DTC delivery instructions, credit such aggregate number of shares of Common Stock to
which the Holder shall be entitled to the Holder’s or its designee’s balance account with DTC through its Deposit Withdrawal
At Custodian system, (B) if the Transfer Agent is not participating in the DTC Fast Automated Securities Transfer Program, issue and deliver
to the address as specified in the Conversion Notice, a certificate or book-entry position, registered in the name of the Holder or its
designee, for the number of shares of Common Stock to which the Holder shall be entitled which certificates shall not bear any restrictive
legends unless required pursuant the Rule 144 or (C) if a restrictive legend is required to be placed on certificates of Common Stock
pursuant to the then existing federal securities laws, issue and deliver to the address as specified in the Conversion Notice, a certificate,
registered in the name of the Holder or its designee, for the number of shares of Common Stock to which the Holder shall be entitled which
certificates shall bear the applicable restrictive legend. If this Note is physically surrendered for conversion and the outstanding Principal
of this Note is greater than the Principal portion of the Conversion Amount being converted, then the Company shall, upon request of the
Holder, as soon as practicable and in no event later than three (3) Business Days after receipt of this Note and at its own expense, issue
and deliver to the holder a new Note representing the outstanding Principal not converted. The Person or Persons entitled to receive the
shares of Common Stock issuable upon a conversion of this Note shall be treated for all purposes as the record holder or holders of such
shares of Common Stock upon the transmission of a Conversion Notice.

 

    5

     

    

 

(ii)
Company’s Failure to Timely Convert. If within three (3) Business Days after the Holder’s transmission of the facsimile,
email, or other form of delivery of the Conversion Notice to the Company, the Company shall fail to issue and deliver to Holder pursuant
to the terms of this Note the number of shares of Common Stock to which the Holder is entitled upon such holder’s conversion of
any Conversion Amount (a “Conversion Failure”), the Original Principal Amount of the Note shall increase by $2,000
per day until the Company issues and delivers the number of shares of Common Stock to which the Holder is entitled to the Holder pursuant
to the terms of this Note (under Holder’s and Company’s expectation that any damages will tack back to the Issuance Date).
If the Company fails to deliver the number of shares of Common Stock to which the Holder is entitled on or before the Share Delivery Date,
resulting in a Conversion Failure, the Holder, at any time prior to selling all of those shares, may rescind any portion, in whole or
in part, of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the Outstanding
Balance with the rescinded conversion shares returned to the Company (under Holder’s and Company’s expectations that any returned
conversion amounts will tack back to the original date of the Note), provided that the rescission of any portion, in whole or in part,
of a Conversion Notice shall not affect the Company’s obligations to make any payments which have accrued prior to the date of such
rescission.

 

(iii)
DWAC/FAST Eligibility.If the Company fails for any reason to deliver to the Holder the Shares by DWAC/FAST electronic transfer
or by delivering a physical stock certificate pursuant to the terms of this Note, or if there is a Conversion Failure as defined in Section
4(b)(ii) of this Note, and if the Holder incurs a Market Price Loss (as defined below), then at any time subsequent to incurring the loss
the Holder may provide the Company written notice indicating the amounts payable to the Holder in respect of the Market Price Loss and
the Company must make the Holder whole by either of the following options at Holder’s election:

 

Market Price Loss = [(High trade price for
the period between the day of conversion and the day the shares clear in the Holder’s brokerage account) x (Number of shares receivable
from the conversion)] – [(Net Sales price realized by Holder) x (Number of shares receivable from the conversion)].

 

Option A – Pay Market Price Loss in
Cash. The Company must pay the Market Price Loss by cash payment, and any such cash payment must be made by the third business day from
the time of the Holder’s written notice to the Company.

 

Option B – Add Market Price Loss to
Outstanding Balance. The Company must pay the Market Price Loss by adding the Market Price Loss to the Outstanding Balance (under Holder’s
and the Company’s expectation that any Market Price Loss amounts will tack back to the Issuance Date).

 

(iv)
Book-Entry. Notwithstanding anything to the contrary set forth herein, upon conversion of any portion of this Note in accordance
with the terms hereof, the Holder shall not be required to physically surrender this Note to the Company unless (A) the full Conversion
Amount represented by this Note is being converted or (B) the Holder has provided the Company with prior written notice (which notice
may be included in a Conversion Notice) requesting reissuance of this Note upon physical surrender of this Note. The Holder and the Company
shall maintain records showing the Principal and Interest converted and the dates of such conversions or shall use such other method,
reasonably satisfactory to the Holder and the Company, so as not to require physical surrender of this Note upon conversion.

 

    6

     

    

 

(c)
Limitations on Conversions or Trading.

 

(i)
Beneficial Ownership. The Company shall not effect any conversions of this Note and the Holder shall not have the right to convert
any portion of this Note or receive shares of Common Stock as payment of interest hereunder to the extent that after giving effect to
such conversion or receipt of such interest payment, the Holder, together with any affiliate thereof, would beneficially own (as determined
in accordance with Section 13(d) of the Exchange Act and the rules promulgated thereunder) in excess of 4.99% of the number of shares
of Common Stock outstanding immediately after giving effect to such conversion. Since the Holder will not be obligated to report to the
Company the number of shares of Common Stock it may hold at the time of a conversion hereunder, unless the conversion at issue would result
in the issuance of shares of Common Stock in excess of 4.99% of the then outstanding shares of Common Stock without regard to any other
shares which may be beneficially owned by the Holder or an affiliate thereof, the Holder shall have the authority and obligation to determine
whether the restriction contained in this Section will limit any particular conversion hereunder and to the extent that the Holder determines
that the limitation contained in this Section applies, the determination of which portion of the principal amount of this Note is convertible
shall be the responsibility and obligation of the Holder. If the Holder has delivered a Conversion Notice for a principal amount of this
Note that, without regard to any other shares that the Holder or its affiliates may beneficially own, would result in the issuance in
excess of the permitted amount hereunder, the Company shall notify the Holder of this fact and shall honor the conversion for the maximum
principal amount permitted to be converted on such Conversion Date in accordance with Section 3(a) and, any principal amount tendered
for conversion in excess of the permitted amount hereunder shall remain outstanding under this Note. The provisions of this Section may
be waived by Holder upon not less than 65 days prior written notification to the Company.

 

(ii)
Capitalization. So long as this as this Note is outstanding, upon written request of the Holder, the Company shall furnish to the
Holder the then-current number of common shares issued and outstanding, the then-current number of common shares authorized, and the then-current
number of shares reserved for third parties.

 

(d)
Other Provisions.

 

(i) Share Reservation. The
Company shall at all times reserve and keep available out of its authorized Common Stock a number of shares equal to at least 2
(two) times the full number of shares of Common Stock issuable upon conversion of all outstanding amounts under this Note; and
within 3 (three) Business Days following the receipt by the Company of a Holder’s notice that such minimum number of shares of
Common Stock is not so reserved, the Company shall promptly reserve a sufficient number of shares of Common Stock to comply with
such requirement.

 

(ii)
Prepayment. At any time prior to the date that an Event of Default occurs under this Note, the Company shall have the option, upon
10 Business Days’ notice (the “Prepayment Notice Period”) to Holder, to pre-pay the entire remaining outstanding principal
amount of this Note in cash, provided that (i) the Company shall pay the Holder (x) 115% of the Outstanding Balance plus (y) accrued
and unpaid interest on the Outstanding Balance, (ii) such amount must be paid in cash on the next Business Day following such the Prepayment
Notice Period, and (iii) so long as Holder is entitled to convert the Note at such time pursuant to the terms of this Note, the Holder
may still convert the Note pursuant to the terms hereof at all times until such prepayment amount has been received in full. Except as
set forth in this Section the Company may not prepay this Note in whole or in part.

 

    7

     

    

 

(iii)
Terms of Future Issuances. So long as this Note is outstanding, upon any issuance by the Company or any of its subsidiaries of
any promissory note, debenture or security (each referred to as a “Security”) (or upon any amendment to or conversion of any
existing Security) with any term more favorable to the holder of such Security or with a term in favor of the holder of such Security
that was not similarly provided to the Holder in this Note, then the Company shall notify the Holder of such additional or more favorable
term and such term, at Holder’s option, shall become a part of the Note. The types of terms contained in another Security that may
be more favorable to the holder of such Security include, but are not limited to, terms addressing conversion discounts, conversion lookback
periods, conversions or exchanges of existing notes or debentures, interest rates, original issue discounts, stock sale price, private
placement price per share, and warrant coverage.

 

(iv)
Dilutive Issuances. If the Company or any subsidiary thereof, as applicable, at any time while this Note is outstanding, shall
sell or grant any option to purchase, or sell or grant any right to re-price, or otherwise dispose of or issue (or announce any offer,
sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock Equivalents entitling any Person to acquire
shares of Common Stock (other than an Exempt Issuance), at an effective price per share less than the then Conversion Price (such lower
price, the “Base Share Price” and such issuances collectively, a “Dilutive Issuance”) (if the holder
of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset
provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued
in connection with such issuance, be entitled to receive shares of Common Stock at an effective price per share which is less than the
Conversion Price, such issuance shall be deemed to have occurred for less than the Conversion Price on such date of the Dilutive Issuance),
then the Conversion Price shall be reduced and only reduced to equal the Base Share Price. Such adjustment shall be made whenever such
Common Stock or Common Stock Equivalents are issued. Notwithstanding the foregoing, the Holder may only enforce its rights under this
Section 4(d)(iv) after the date that is one hundred eighty (180) calendar days after the Issuance Date, provided, however, that at such
time the Holder may enforce its rights to all adjustments hereunder that apply even if the Dilutive Issuance occurred prior to the date
that is one hundred eighty (180) calendar days after the Issuance Date. “Exempt Issuance” shall mean: (i) Common Stock
and Common Stock Equivalents issued pursuant to an Uplist Offering, (ii) Common Stock or Common Stock Equivalents issued to employees
or directors of, or consultants, advisors or service providers to, the Company or any of its subsidiaries pursuant to a plan, agreement
or arrangement approved by the Board of Directors of the Company, (iii) shares Common Stock actually issued upon the exercise of
Common Stock Equivalents for which an adjustment has already been made pursuant to this Section 4(d)(iv), (iv) Common Stock and Common
Stock Equivalents issued to banks, equipment lessors or other financial institutions, or to real property lessors, pursuant to a debt
financing, equipment leasing or real property leasing transaction approved by the Board of Directors of the Company, (v)  Common
Stock and Common Stock Equivalents issued to suppliers or third party service providers in connection with the provision of goods or services
pursuant to transactions approved by the Board of Directors of the Company, (vi) Common Stock and Common Stock Equivalents issued
as acquisition consideration pursuant to the acquisition of another business by the Company by merger, purchase of substantially all of
the assets or other reorganization or to a joint venture agreement, provided that such issuances are approved by the Board of Directors
of the Company, and (vii) Common Stock and Common Stock Equivalents issued in connection with sponsored research, collaboration,
technology license, development, OEM, marketing or other similar agreements or strategic partnerships approved by the Board of Directors
of the Company.

 

(v) Notice of Dilution Issuance.
The Company shall notify the Holder in writing, no later than the Trading Day following a Dilutive Issuance subject to Section 4(d)(iv),
indicating therein the applicable issuance price, or applicable reset price, exchange price, conversion price and other pricing terms
(such notice, the “Dilutive Issuance Notice”). For purposes of clarification, whether or not the Company provides a
Dilutive Issuance Notice pursuant to this Section 4(d)(v), upon the occurrence of any Dilutive Issuance, after the date of such Dilutive
Issuance the Holder is entitled to receive a number of shares based upon the Base Share Price regardless of whether the Holder accurately
refers to the Base Share Price in the Conversion Notice. All calculations under this Section 3 shall be rounded up to the nearest $0.00001
or whole share.

 

    8

     

    

 

(vi) Nothing herein shall limit
a Holder’s right to pursue actual damages or declare an Event of Default pursuant to Section 3 herein for the Company’s failure
to deliver shares of Common Stock upon conversion within the period specified herein and such Holder shall have the right to pursue all
remedies available to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief,
in each case without the need to post a bond or provide other security. The exercise of any such rights shall not prohibit the Holder
from seeking to enforce damages pursuant to any other Section hereof or under applicable law.

 

(5)
PIGGYBACK REGISTRATION RIGHTS. The Company shall include all shares issuable upon conversion of this Note for resale by Holder
at prevailing market prices (and not fixed prices) on the first registration statement the Company files with the SEC after the Uplist
Offering.

 

(6)
REISSUANCE OF THIS NOTE.

 

(a)
Assignability. The Company may not assign this Note. This Note will be binding upon the Company and its successors and will inure
to the benefit of the Holder and its successors and assigns and may be assigned by the Holder to anyone of its choosing without Company’s
approval.

 

(b)
Lost, Stolen or Mutilated Note. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Note, and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder
to the Company in customary form and, in the case of mutilation, upon surrender and cancellation of this Note, the Company shall execute
and deliver to the Holder a new Note representing the outstanding Principal.

 

(7)
NOTICES. Any notices, consents, waivers or other communications required or permitted to be given under the terms hereof must be
in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile
(provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending party) (iii) upon receipt,
when sent by email; or (iv) one (1) Trading Day after deposit with a nationally recognized overnight delivery service, in each case properly
addressed to the party to receive the same. The addresses and facsimile numbers for such communications shall be those set forth in the
communications and documents that each party has provided the other immediately preceding the issuance of this Note or at such other address
and/or facsimile number and/or to the attention of such other person as the recipient party has specified by written notice given to each
other party three (3) Business Days prior to the effectiveness of such change. Written confirmation of receipt (i) given by the recipient
of such notice, consent, waiver or other communication, (ii) mechanically or electronically generated by the sender’s facsimile
machine containing the time, date, recipient facsimile number and an image of the first page of such transmission or (iii) provided by
a nationally recognized overnight delivery service, shall be rebuttable evidence of personal service, receipt by facsimile or receipt
from a nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above, respectively.

 

The addresses for such communications shall be:

 

If to the Company, to:

 

Home Bistro, Inc.

4014 Chase Avenue, #212

Miami Beach, FL 33140

Attn: Zalmi Duchman

Email: zalmi@homebistro.com

 

    9

     

    

 

If to the Holder, to:

 

GS Capital Partners, LLC

1 East Liberty Street, Suite 600

Reno, NV 89501

Attention: Isaac Kastner

Email: isaac@gscapitalfund.com

 

(8) APPLICABLE
LAW AND VENUE. This Note shall be governed by and construed in accordance with the laws of the State of Nevada, without giving effect
to conflicts of laws thereof. Any action brought by either party against the other concerning the transactions contemplated by this Agreement
shall be brought only in the state courts of Nevada or in the federal courts located in Nevada. Both parties and the individuals signing
this Agreement agree to submit to the jurisdiction of such courts.

 

(9) WAIVER.
Any waiver by the Holder of a breach of any provision of this Note shall not operate as or be construed to be a waiver of any other breach
of such provision or of any breach of any other provision of this Note. The failure of the Holder to insist upon strict adherence to any
term of this Note on one or more occasions shall not be considered a waiver or deprive that party of the right thereafter to insist upon
strict adherence to that term or any other term of this Note. Any waiver must be in writing.

 

(10) LIQUIDATED
DAMAGES. Holder and Company agree that in the event Company fails to comply with any of the terms or provisions of this Note, Holder’s
damages would be uncertain and difficult (if not impossible) to accurately estimate because of the parties’ inability to predict
future interest rates, future share prices, future trading volumes and other relevant factors. Accordingly, Holder and Company agree that
any fees, balance adjustments, default interest or other charges assessed under this Note are not penalties but instead are intended by
the parties to be, and shall be deemed, liquidated damages (under Holder’s and Company’s expectations that any such liquidated
damages will tack back to the Closing Date for purposes of determining the holding period under Rule 144).

 

(11) ADJUSTMENTS.
Notwithstanding anything to the contrary, the Conversion Price is subject to equitable adjustments for stock splits (including reverse
stock splits and forward stock splits), stock dividends or rights offerings by the Company relating to the Company’s securities
or the securities of any subsidiary of the Company, combinations, recapitalization, reclassifications, extraordinary distributions and
similar events.

 

(12) USURY.
To the extent it may lawfully do so, the Company hereby agrees not to insist upon or plead or in any manner whatsoever claim, and will
resist any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at any time hereafter
in force, in connection with any action or proceeding that may be brought by the Holder in order to enforce any right or remedy under
this Note. Notwithstanding any provision to the contrary contained in this Note, it is expressly agreed and provided that the total liability
of the Company under this Note for payments which under the applicable law are in the nature of interest shall not exceed the maximum
lawful rate authorized under applicable law (the “Maximum Rate”), and, without limiting the foregoing, in no event shall any
rate of interest or default interest, or both of them, when aggregated with any other sums which under the applicable law in the nature
of interest that the Company may be obligated to pay under this Note exceed such Maximum Rate. It is agreed that if the maximum contract
rate of interest allowed by applicable law and applicable to this Note is increased or decreased by statute or any official governmental
action subsequent to the Issuance Date, the new maximum contract rate of interest allowed by law will be the Maximum Rate applicable to
this Note from the effective date thereof forward, unless such application is precluded by applicable law. If under any circumstances
whatsoever, interest in excess of the Maximum Rate is paid by the Company to the Holder with respect to indebtedness evidenced by this
the Note, such excess shall be applied by the Holder to the unpaid principal balance of any such indebtedness or be refunded to the Company,
the manner of handling such excess to be at the Holder’s election.

 

    10

     

    

 

(13) SEVERABILITY.
In the event that any provision of this Note is invalid or unenforceable under any applicable statute or rule of law (including any judicial
ruling), then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to
conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the
validity or enforceability of any other provision of this Note.

 

(14) NO BROKER-DEALER ACKNOWLEDGEMENT. Absent a final adjudication from a court of competent jurisdiction stating otherwise, so long
as any obligation of Company under this Note, Securities Purchase Agreement or the other documents in connection with the transactions
contemplated hereunder (the “Transaction Documents”) is outstanding, the Company shall not state, claim, allege, or in any
way assert to any person, institution, or entity, that Holder is currently, or ever has been, a broker-dealer under the Securities Exchange
Act of 1934.

 

(15) OPPORTUNITY TO CONSULT WITH COUNSEL. The Company represents and acknowledges that it has been provided with the opportunity to
discuss and review the terms of this Note and the other Transaction Documents with its counsel before signing it and that it is freely
and voluntarily signing the Transaction Documents in exchange for the benefits provided herein. In light of this, the Company will not
contest the validity of Transaction Documents and the transactions contemplated therein. The Company further represents and acknowledges
that it has been provided a reasonable period of time within which to review the terms of the Note and related transaction documents.

 

[Signature Page Follows]

 

    11

     

    

 

IN WITNESS WHEREOF, the
Company has caused this Convertible Note to be duly executed by a duly authorized officer as of the date set forth above.

 

	THE COMPANY:	 
	Home Bistro, Inc.	 
	 	 
	By:	/s/ Zalmi Duchman	 
	 	Zalmi Duchman	 
	 	Chief Executive Officer	 

 

[Signature Page to Convertible Note No. HBIS-2]

 

     

     

    

 

EXHIBIT A

 

NOTICE OF CONVERSION

 

The undersigned hereby elects
to convert $_________________principal amount of the Note (defined below) together with $________________ of accrued and unpaid interest
thereto, totaling $_____________ into that number of shares of Common Stock to be issued pursuant
to the conversion of the Note (“Common Stock”) as set forth below, of Home Bistro Inc., a Nevada corporation (the “Company”),
according to the conditions of the convertible note of the Company dated as of May __, 2022 (the “Note”), as of the date written
below. No fee will be charged to the Holder for any conversion, except for transfer taxes, if any.

 

Box Checked as to applicable instructions:

 

☐ The
Company shall electronically transmit the Common Stock issuable pursuant to this Notice of Conversion to the account of the undersigned
or its nominee with DTC through its Deposit Withdrawal At Custodian system (“DWAC Transfer”).

 

Name of DTC Prime Broker:

 

Account Number:

 

☐ The
undersigned hereby requests that the Company issue a certificate or certificates for the number of shares of Common Stock set forth below
(which numbers are based on the Holder’s calculation attached hereto) in the name(s) specified immediately below or, if additional
space is necessary, on an attachment hereto:

 

Name: [NAME]

Address: [ADDRESS]

 

Date of Conversion: _____________

Applicable Conversion Price: $____________

Number of Shares of Common Stock to be
Issued

Pursuant to Conversion of the Notes:
______________

Amount of Principal Balance Due remaining

Under the Note after this
conversion: ______________

Accrued and unpaid interest
remaining: ______________

 

	 	GS CAPITAL PARTNERS, LLC	 
	 	 	 
	 	By:	              	 
	 	Name:	 
	 	Title:	 
	 	Date:	 

 

     

     

    

 

EXHIBIT B

 

Wire Instructions

 

See attached.Exhibit
10.4

 

SECURITIES
PURCHASE AGREEMENT

 

This
SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of May 24, 2022, is entered into by and between
HOME BISTRO, INC., INC., a Nevada corporation, (the “Company”), and Jefferson Street Capital LLC, a New Jersey limited
liability company (the “Buyer”).

 

A.
The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the “SEC”) under
the Securities Act of 1933, as amended (the “1933 Act”).

 

B.
Upon the terms and conditions stated in this Agreement, the Buyer desires to purchase and the Company desires to issue and sell, upon
the terms and conditions set forth in this Agreement (i) a Promissory Note of the Company, in the form attached hereto as Exhibit
A, in the original principal amount of $125,000 (together with any note(s) issued in replacement thereof or as a dividend thereon
or otherwise with respect thereto in accordance with the terms thereof, the “Note”), and (ii) a three-year share purchase
warrant entitling the Buyer to acquire 217,391 common shares of the Company (“Common Stock”), in the form attached
hereto as Exhibit B (the “Warrant”).

 

NOW
THEREFORE, the Company and the Buyer hereby agree as follows:

 

1.
Purchase and Sale. On the Closing Date (as defined
below), the Company shall issue and sell to the Buyer and the Buyer agrees to purchase from the Company (i) the Note in the original
principal amount of $125,000 and (ii) the Warrant to purchase shares of Common Stock.

 

1.1
Form of Payment. On the Closing Date, (i) the Buyer shall pay the purchase price of $112,500 (the “Purchase Price”)
for the Securities (as defined in this Agreement) to be issued and sold to it at the Closing (as defined below) by wire transfer of immediately
available funds in accordance with the Company’s written wiring instructions, against delivery of the Securities, and (ii) the
Company shall deliver such duly executed Securities on behalf of the Company, to the Buyer, against delivery of such Purchase Price.

 

1.2
Closing Date. The date and time of the issuance and sale of the Securities pursuant to this Agreement (the “Closing Date”)
shall be on or about May 24, 2022, or such other mutually agreed upon time. The closing of the transactions contemplated by this Agreement
(the “Closing”) shall occur on the Closing Date at such location as may be agreed to by the parties.

 

2.
Buyer’s Representations and Warranties.
The Buyer represents and warrants to the Company as of the Closing Date that:

 

a.
Authorization. This Agreement has been duly and validly authorized, executed and delivered on behalf of the Buyer and is a valid
and binding agreement of the Buyer enforceable against Buyer in accordance with its terms, subject as to enforceability to general principles
of equity and to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting
generally, the enforcement of applicable creditors’ rights and remedies. The Buyer has the requisite power and authority to enter
into and perform its obligations under this Agreement and each other agreement entered into by the parties hereto in connection with
the transactions contemplated by this Agreement.

 

b.
Conflicts. The execution, delivery and performance of this Agreement by the Buyer and the consummation by the Buyer of the transactions
contemplated hereby will not (i) if applicable, result in a violation of the certificate of incorporation, by-laws or other documents
of organization of the Buyer, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would
become a default) under, or give others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture
or instrument to which the Buyer is bound, or (iii) result in a violation of any law, rule, regulation or decree applicable to the Buyer.

 

    1

     

    

 

c.
Investment Purpose. As of the Closing Date, the Buyer is purchasing the Note and Warrant and the shares of Common Stock that may
be issuable upon conversion or exercise of or otherwise pursuant to the Note and Warrant and such additional shares of Common Stock,
if any, as are issuable on account of interest on the Note pursuant to this Agreement (such shares of Common Stock being collectively
referred to herein as the “Underlying Shares”) for its own account and not with a present view towards the public
sale or distribution thereof, except pursuant to sales registered or exempted from registration under the 1933 Act; provided,
however, that by making the representations herein, the Buyer does not agree to hold any of the Securities for any minimum or
other specific term and reserves the right to dispose of the Securities at any time in accordance with or pursuant to a registration
statement or an exemption under the 1933 Act. “Securities” shall mean the Note, Warrant, shares of Common Stock that
may be issuable upon conversion or exercise of or otherwise pursuant to the Note and Warrant, and such additional shares of Common Stock,
if any, as are issuable on account of interest on the Note pursuant to this Agreement.

 

d.
Accredited Investor Status. The Buyer is an “accredited investor” as that term is defined in Rule 501(a) of Regulation
D (an “Accredited Investor”).

 

e.
Reliance on Exemptions. The Buyer understands that the Securities are being offered and sold to it in reliance upon specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying upon the truth
and accuracy of, and the Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and understandings
of the Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of the Buyer to acquire the
Securities.

 

f.
Information. The Buyer and its advisors, if any, have been, and for so long as the Note remains outstanding will continue to be,
furnished with all materials relating to the business, finances and operations of the Company and materials relating to the offer and
sale of the Securities which have been requested by the Buyer or its advisors. The Buyer and its advisors, if any, have been, and for
so long as the Note remains outstanding will continue to be, afforded the opportunity to ask questions of the Company regarding its business
and affairs. Notwithstanding the foregoing, the Company has not disclosed to the Buyer any material nonpublic information regarding the
Company or otherwise and will not disclose such information unless such information is disclosed to the public prior to or promptly following
such disclosure to the Buyer. Neither such inquiries nor any other due diligence investigation conducted by Buyer or any of its advisors
or representatives shall modify, amend or affect Buyer’s right to rely on the Company’s representations and warranties contained
in Section 3 below.

 

g.
Governmental Review. The Buyer understands that no United States federal or state agency or any other government or governmental
agency has passed upon or made any recommendation or endorsement of the Securities.

 

h.
Transfer or Re-sale. The Buyer understands that (i) the sale or resale of the Securities has not been and is not being registered
under the 1933 Act or any applicable state securities laws, and the Securities may not be transferred unless (a) the Securities are sold
pursuant to an effective registration statement under the 1933 Act, (b) the Buyer shall have delivered to the Company, at the cost of
the Company, an opinion of counsel that shall be in form, substance and scope customary for opinions of counsel in comparable transactions
to the effect that the Securities to be sold or transferred may be sold or transferred pursuant to an exemption from such registration,
which opinion shall be accepted by the Company, (c) the Securities are sold or transferred to an “affiliate” (as defined
in Rule 144 promulgated under the 1933 Act (or a successor rule) (“Rule 144”)) of the Buyer who agrees to sell or
otherwise transfer the Securities only in accordance with this Section 2(f) and who is an Accredited Investor, (d) the Securities are
sold pursuant to Rule 144 or other applicable exemption, or (e) the Securities are sold pursuant to Regulation S under the 1933 Act (or
a successor rule) (“Regulation S”), and the Buyer shall have delivered to the Company, at the cost of the Company,
an opinion of counsel that shall be in form, substance and scope customary for opinions of counsel in corporate transactions, which opinion
shall be accepted by the Company; (ii) any sale of such Securities made in reliance on Rule 144 may be made only in accordance with the
terms of said Rule and further, if said Rule is not applicable, any re-sale of such Securities under circumstances in which the seller
(or the person through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the 1933 Act) may require
compliance with some other exemption under the 1933 Act or the rules and regulations of the SEC thereunder; and (iii) neither the Company
nor any other person is under any obligation to register such Securities under the 1933 Act or any state securities laws or to comply
with the terms and conditions of any exemption thereunder (in each case). Notwithstanding the foregoing or anything else contained herein
to the contrary, the Securities may be pledged in connection with a bona fide margin account or other lending arrangement secured
by the Securities, and such pledge of Securities shall not be deemed to be a transfer, sale or assignment of the Securities hereunder,
and the Buyer in effecting such pledge of Securities shall be not required to provide the Company with any notice thereof or otherwise
make any delivery to the Company pursuant to this Agreement or otherwise.

 

    2

     

    

 

i.
Legends. The Buyer understands that until such time as the Securities have been registered under the 1933 Act or may be sold pursuant
to Rule 144, Rule 144A under the 1933 Act, Regulation S, or other applicable exemption without any restriction as to the number of securities
as of a particular date that can then be immediately sold, the Securities may bear a restrictive legend in substantially the following
form (and a stop-transfer order may be placed against transfer of the such Securities):

 

“NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE [CONVERTIBLE/EXERCISABLE]
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED
FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM,
THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144, RULE 144A, REGULATION S, OR OTHER APPLICABLE
EXEMPTION UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT
OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”

 

The
legend set forth above shall be removed and the Company shall issue a certificate or book entry statement for the applicable shares of
Common Stock without such legend to the holder of any Security upon which it is stamped or (as requested by such holder) issue the applicable
shares of Common Stock to such holder by electronic delivery by crediting the account of such holder’s broker with The Depository
Trust Company (“DTC”), if, unless otherwise required by applicable state securities laws, (a) such Security is registered
for sale under an effective registration statement filed under the 1933 Act or otherwise may be sold pursuant to Rule 144, Rule 144A,
Regulation S, or other applicable exemption without any restriction as to the number of securities as of a particular date that can then
be immediately sold, or (b) the Company or the Buyer provides a customary legal opinion letter of its counsel to the effect that a public
sale or transfer of such Security may be made without registration under the 1933 Act, which opinion shall be accepted by the Company
so that the sale or transfer is effected. The Company shall be responsible for the fees of its transfer agent and all DTC fees associated
with any such issuance. The Buyer agrees to sell all Securities, including those represented by a certificate(s) from which the legend
has been removed, in compliance with applicable prospectus delivery requirements, if any.

 

j.
Authorization; Enforcement. This Agreement has been duly and validly authorized by the Buyer and has been duly executed and delivered
on behalf of the Buyer, and this Agreement constitutes a valid and binding agreement of the Buyer enforceable in accordance with its
terms, except as enforcement may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting creditors’
rights generally and except as may be limited by the exercise of judicial discretion in applying principles of equity.

 

k. Broker-Dealer.
The Buyer is not registered as a broker or dealer under Section 15(a) of the Securities Exchange Act of 1934, as amended, affiliated
with any broker or dealer registered under Section 15(a) of the Securities Exchange Act of 1934, as amended, or a member of the
Financial Industry Regulatory Authority.

 

l.
Residency. The Buyer is a resident of the jurisdiction set forth immediately below the Buyer’s name on the signature pages
hereto.

 

m.
Acknowledgement Regarding Buyer’s Trading Activity. Until the Note is fully repaid or fully converted, the Buyer shall not
effect any “short sale” (as such term is defined in Rule 200 of Regulation SHO of the 1934 Act) of the Common Stock which
establishes a net short position with respect to the Common Stock.

 

    3

     

    

 

3.
Representations and Warranties of the Company.
The Company represents and warrants to the Buyer as of the Closing Date that:

 

a.
Organization and Qualification. The Company and each of its Subsidiaries (as defined below), if any, is a corporation duly organized,
validly existing and in good standing under the laws of the jurisdiction in which it is incorporated, with full power and authority (corporate
and other) to own, lease, use and operate its properties and to carry on its business as and where now owned, leased, used, operated
and conducted. The SEC Documents (as defined in this Agreement) set forth a list of all of the Subsidiaries of the Company and the jurisdiction
in which each is incorporated. The Company and each of its Subsidiaries is duly qualified as a foreign corporation to do business and
is in good standing in every jurisdiction in which its ownership or use of property or the nature of the business conducted by it makes
such qualification necessary except where the failure to be so qualified or in good standing would not have a Material Adverse Effect.
“Material Adverse Effect” means any material adverse effect on the business, operations, assets, financial condition
or prospects of the Company or its Subsidiaries, if any, taken as a whole, or on the transactions contemplated hereby or by the agreements
or instruments to be entered into in connection herewith. “Subsidiaries” means any corporation or other organization,
whether incorporated or unincorporated, in which the Company owns, directly or indirectly, any equity or other ownership interest.

 

b.
Authorization; Enforcement. (i) The Company has all requisite corporate power and authority to enter into and perform this Agreement,
the Note, the Warrant, and to consummate the transactions contemplated hereby and thereby and to issue the Securities, in accordance
with the terms hereof and thereof, (ii) the execution and delivery of this Agreement, the Note, Warrant, Underlying Shares, and the Securities
by the Company and the consummation by it of the transactions contemplated hereby and thereby (including without limitation, the issuance
of the Note as well as the issuance and reservation for issuance of the Underlying Shares that may be issuable upon conversion of the
Note and exercise of the Warrant) have been duly authorized by the Company’s Board of Directors and no further consent or authorization
of the Company, its Board of Directors, its shareholders, or its debt holders is required, (iii) this Agreement and the Note (together
with any other instruments executed in connection herewith or therewith) have been duly executed and delivered by the Company by its
authorized representative, and such authorized representative is the true and official representative with authority to sign this Agreement,
the Note and the other instruments documents executed in connection herewith or therewith and bind the Company accordingly, and (iv)
this Agreement constitutes, and upon execution and delivery by the Company of the Note, each of such instruments will constitute, a legal,
valid and binding obligation of the Company, enforceable against the Company in accordance with their terms.

 

c.
Capitalization; Governing Documents. As of May 9, 2022, the authorized capital stock of the Company consists of: 1,000,000,000
authorized shares of Common Stock, of which 37,361,606 shares were issued and outstanding, 20,000,000 authorized shares of preferred
stock, of which 0 were issued and outstanding and 500,000 authorized shares of convertible Series B preferred stock, of which 0 were
issued and outstanding. All of such outstanding shares of capital stock of the Company and the Underlying Shares, are, or upon issuance
will be, duly authorized, validly issued, fully paid and non-assessable. No shares of capital stock of the Company are subject to preemptive
rights or any other similar rights of the shareholders of the Company or any liens or encumbrances imposed through the actions or failure
to act of the Company. As of the effective date of this Agreement, other than as publicly announced prior to such date and reflected
in the reports, schedules, forms, statements and other documents filed by the Company with the SEC (all of the foregoing filed prior
to the date hereof are referred to as the “SEC Documents”), (i) there are no outstanding options, warrants, scrip,
rights to subscribe for, puts, calls, rights of first refusal, agreements, understandings, claims or other commitments or rights of any
character whatsoever relating to, or securities or rights convertible into or exchangeable for any shares of capital stock of the Company
or any of its Subsidiaries, or arrangements by which the Company or any of its Subsidiaries is or may become bound to issue additional
shares of capital stock of the Company or any of its Subsidiaries, (ii) there are no agreements or arrangements under which the Company
or any of its Subsidiaries is obligated to register the sale of any of its or their securities under the 1933 Act and (iii) there are
no anti-dilution or price adjustment provisions contained in any security issued by the Company (or in any agreement providing rights
to security holders) that will be triggered by the issuance of any of the Securities. The Company has furnished to the Buyer true and
correct copies of the Company’s Certificate of Incorporation as in effect on the date hereof (“Certificate of Incorporation”),
the Company’s By-laws, as in effect on the date hereof (the “By-laws”), and the terms of all securities convertible
into or exercisable for Common Stock of the Company and the material rights of the holders thereof in respect thereto.

 

    4

     

    

 

4.
Covenants

 

4.1
Repayment from Proceeds. If, at any time prior to the full repayment or full conversion of all amounts owed under the Note, the
Company receives cash proceeds from an offering of Common Stock (or units consisting of
Common Stock and warrants to purchase Common Stock) that will result in the immediate listing for trading of the Common Stock on the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, or
any other national securities exchange (or any successors to any of the foregoing) (an “Uplist
Offering”), the Company shall, within one (1) business day of Company’s receipt of such proceeds, inform the Buyer
of or publicly disclose such Uplist Offering, following which the Buyer shall have the right in its sole discretion to require the Company
to immediately apply the proceeds received by the Company pursuant to the Uplist Offering to repay all or any portion of the outstanding
Principal and Interest (including any Default Interest) then due under the Note. If, at any time after the date that is 180 days after
the Closing Date and the Company has failed to consummate an Uplist Offering prior to such date, the Company receives cash proceeds from
the sale of any convertible securities, the issuance of equity or debt, the conversion of
outstanding warrants of the Company, or the issuance of securities pursuant to an equity line of credit of the Company in a registered
offering, the Company shall, within one (1) business day of Company’s receipt of such proceeds, inform the Buyer of or publicly
disclose the receipt of proceeds of such offering, following which the Buyer shall have the right in its sole discretion to require the
Company to immediately apply the proceeds received by the Company pursuant to such offering to repay up to 50% of the outstanding Principal
and Interest (including any Default Interest) then due under the Note. Failure of the Company
to comply with this provision shall constitute an Event of Default.

 

4.2
Reserved Amount. Company covenants that during the period while any outstanding balance
is owing under the Note or any exercise of the Warrant is available, the Company
will reserve from its authorized and unissued Common Stock a number of shares, free from preemptive rights, equal to two (2) times the
number of shares that is actually issuable upon full conversion of the Note (based on the Conversion Price of the Notes in effect from
time to time) and exercise of the Warrant (the “Reserved Amount”).

 

4.3
Replacement of Transfer Agent. The Company shall
not replace its transfer agent without the written consent of the Buyer.

 

4.4
No Conflicts. The execution, delivery and performance of this Agreement, Note and Warrant, by the Company and the consummation
by the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Securities) will
not (i) conflict with or result in a violation of any provision of the Certificate of Incorporation or By-laws of the Company, or (ii)
violate or conflict with, or result in a breach of any provision of, or constitute a default (or an event which with notice or lapse
of time or both could become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of,
any agreement, note, evidence of indebtedness, indenture, patent, patent license or instrument to which the Company or any of its Subsidiaries
is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities
laws and regulations and regulations of any self-regulatory organizations to which the Company or its securities is subject) applicable
to the Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected
(except for such conflicts, defaults, terminations, amendments, accelerations, cancellations and violations as would not, individually
or in the aggregate, have a Material Adverse Effect), or (iv) trigger any anti- dilution and/or ratchet provision contained in any other
contract in which the Company is a party thereto or any security issued by the Company. Neither the Company nor any of its Subsidiaries
is in violation of its Certificate of Incorporation, By-laws or other organizational documents and neither the Company nor any of its
Subsidiaries is in default (and no event has occurred which with notice or lapse of time or both could put the Company or any of its
Subsidiaries in default) under, and neither the Company nor any of its Subsidiaries has taken any action or failed to take any action
that would give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument
to which the Company or any of its Subsidiaries is a party or by which any property or assets of the Company or any of its Subsidiaries
is bound or affected, except for possible defaults as would not, individually or in the aggregate, have a Material Adverse Effect. The
businesses of the Company and its Subsidiaries, if any, are not being conducted, and shall not be conducted so long as the Buyer owns
any of the Securities, in violation of any law, ordinance or regulation of any governmental entity. Except as specifically contemplated
by this Agreement and as required under the 1933 Act and any applicable state securities laws, the Company is not required to obtain
any consent, authorization or order of, or make any filing or registration with, any court, governmental agency, regulatory agency, self-regulatory
organization or stock market or any third party in order for it to execute, deliver or perform any of its obligations under this Agreement,
the Note, and Warrant, in accordance with the terms hereof or thereof or to issue and sell the Securities in accordance. All consents,
authorizations, orders, filings and registrations which the Company is required to obtain pursuant to the preceding sentence have been
obtained or effected on or prior to the date hereof. The Company is not in violation of the listing requirements of the Primary Market
(as defined in the Note) and does not reasonably anticipate that the Common Stock will be delisted by the Primary Market in the foreseeable
future. The Company and its Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

 

    5

     

    

 

4.5
SEC Documents. As of their respective dates, the SEC Documents complied in all material respects with the requirements of the
1934 Act and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and none of the SEC Documents,
at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made,
not misleading. None of the statements made in any such SEC Documents is, or has been, required to be amended or updated under applicable
law (except for such statements as have been amended or updated in subsequent filings prior the date hereof). As of their respective
dates, the financial statements of the Company included in the SEC Documents complied as to form in all material respects with applicable
accounting requirements and the published rules and regulations of the SEC with respect thereto. Such financial statements have been
prepared in accordance with United States generally accepted accounting principles, consistently applied, during the periods involved
and fairly present in all material respects the consolidated financial position of the Company and its consolidated Subsidiaries as of
the dates thereof and the consolidated results of their operations and cash flows for the periods then ended (subject, in the case of
unaudited statements, to normal year-end audit adjustments). Except as set forth in the financial statements of the Company included
in the SEC Documents, the Company has no liabilities, contingent or otherwise, other than (i) liabilities incurred in the ordinary course
of business subsequent to January 31, 2022, and (ii) obligations under contracts and commitments incurred in the ordinary course of business
and not required under generally accepted accounting principles to be reflected in such financial statements, which, individually or
in the aggregate, are not material to the financial condition or operating results of the Company. The Company is subject to the reporting
requirements of the 1934 Act.

 

4.6
Absence of Certain Changes. Since January 31, 2022, there has been no material adverse change and no material adverse development
in the assets, liabilities, business, properties, operations, financial condition, results of operations, prospects or 1934 Act reporting
status of the Company or any of its Subsidiaries.

 

4.7
Absence of Litigation. Other than as disclosed in the SEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation
before or by any court, public board, government agency, self- regulatory organization or body pending or, to the knowledge of the Company
or any of its Subsidiaries, threatened against or affecting the Company or any of its Subsidiaries, or their officers or directors in
their capacity as such, that could have a Material Adverse Effect. The SEC Documents contain a complete list and summary description
of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its Subsidiaries.
The Company and its Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

 

4.8
Permits; Compliance. The Company and each of its Subsidiaries is in possession of all franchises, grants, authorizations, licenses,
permits, easements, variances, exemptions, consents, certificates, approvals and orders necessary to own, lease and operate its properties
and to carry on its business as it is now being conducted (collectively, the “Company Permits”), and there is no action
pending or, to the knowledge of the Company, threatened regarding suspension or cancellation of any of the Company Permits. Neither the
Company nor any of its Subsidiaries is in conflict with, or in default or violation of, any of the Company Permits, except for any such
conflicts, defaults or violations which, individually or in the aggregate, would not reasonably be expected to have a Material Adverse
Effect. Since January 31, 2022, neither the Company nor any of its Subsidiaries has received any notification with respect to possible
conflicts, defaults or violations of applicable laws, except for notices relating to possible conflicts, defaults or violations, which
conflicts, defaults or violations would not have a Material Adverse Effect.

 

5.
Governing Law; Miscellaneous.

 

5.1.
Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Nevada without regard
to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by
this Agreement shall be brought only in the state courts located in New Jersey or in the federal courts located in New Jersey. The parties
to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert
any defense based on lack of jurisdiction or venue or based upon forum non conveniens. In the event that any provision of this
Agreement or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of
law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform
with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity
or enforceability of any other provision of any agreement. Each party hereby irrevocably waives personal service of process and consents
to process being served in any suit, action or proceeding in connection with this Agreement or any other document entered into by the
Company in connection with this Agreement (collectively, the “Transaction Documents”) by mailing a copy thereof via
registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to
it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. THE COMPANY HEREBY
IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR
IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

    6

     

    

 

5.2.
Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of
which shall constitute one and the same agreement and shall become effective when counterparts have been signed by each party and delivered
to the other party.

 

5.3.
Headings. The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the interpretation
of, this Agreement.

 

5.4.
Severability. In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule
of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to
conform with such statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect
the validity or enforceability of any other provision hereof.

 

5.5.
Entire Agreement; Amendments. This Agreement and the instruments referenced herein contain the entire understanding of the parties
with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither the Company nor
the Buyer makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement may
be waived or amended other than by an instrument in writing signed by the Buyer.

 

5.6.
Notices. Any notice required or permitted hereunder shall be given in writing (unless otherwise specified herein) and shall be
deemed effectively given on the earliest of:

 

(a)
the date delivered, if delivered by personal delivery as against written receipt therefor or by e-mail to an executive officer, or by
confirmed facsimile,

 

(b)
the fifth Trading Day (as defined in the Note) after deposit, postage prepaid, in the United States Postal Service by registered or certified
mail, or

 

(c)
the third Trading Day (as defined in the Note) after mailing by domestic or international express courier, with delivery costs and fees
prepaid, in each case, addressed to each of the other parties thereunto entitled at the following addresses (or at such other addresses
as such party may designate by ten (10) calendar days’ advance written notice similarly given to each of the other parties hereto):

 

If
to the Company, to:

 

Home
Bistro, Inc., Inc.

4014
Chase Avenue, #212

Miami
Beach, FL 33140

Attn:
Zalmi Duchman

Email:
zalmi@homebistro.com

 

If
to the Buyer: to the address and email set forth on the signature page hereto

 

    7

     

    

 

5.7.
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
assigns. Notwithstanding anything to the contrary herein, the rights, interests or obligations of the Company hereunder may not be assigned,
by operation of law or otherwise, in whole or in part, by the Company without the prior written consent of the Buyer, which consent may
be withheld at the sole discretion of the Buyer; provided, however, that in the case of a merger, sale of substantially all of
the Company’s assets or other corporate reorganization, the Buyer shall not unreasonably withhold, condition or delay such consent.
This Agreement or any of the severable rights and obligations inuring to the benefit of or to be performed by Buyer hereunder may be
assigned by Buyer to a third party, including its financing sources, in whole or in part, without the need to obtain the Company’s
consent thereto.

 

5.8.
Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors
and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.

 

5.9.
Survival. The representations and warranties of the Company and the agreements and covenants set forth in this Agreement shall
survive the Closing hereunder notwithstanding any due diligence investigation conducted by or on behalf of the Buyer. The Company agrees
to indemnify and hold harmless the Buyer and all its officers, directors, employees, attorneys, and agents for loss or damage arising
as a result of or related to any breach or alleged breach by the Company of any of its representations, warranties and covenants set
forth in this Agreement or any of its covenants and obligations under this Agreement, including advancement of expenses as they are incurred.

 

5.10.
No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party.

 

5.11.
Remedies. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Buyer by
vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the Company acknowledges that the remedy at law
for a breach of its obligations under this Agreement will be inadequate and agrees, in the event of a breach or threatened breach by
the Company of the provisions of this Agreement, that the Buyer shall be entitled, in addition to all other available remedies at law
or in equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing any
breach of this Agreement and to enforce specifically the terms and provisions hereof, without the necessity of showing economic loss
and without any bond or other security being required.

 

5.12.
Buyer’s Rights and Remedies Cumulative. All rights, remedies, and powers conferred in this Agreement and the Transaction
Documents on the Buyer are cumulative and not exclusive of any other rights or remedies, and shall be in addition to every other right,
power, and remedy that the Buyer may have, whether specifically granted in this Agreement or any other Transaction Documents, or existing
at law, in equity, or by statute; and any and all such rights and remedies may be exercised from time to time and as often and in such
order as the Buyer may deem expedient.

 

5.13.
Attorneys’ Fees and Cost of Collection. In the event of any action at law or in equity to enforce or interpret the terms
of this Agreement or any of the other Transaction Documents, the parties agree that the party who is awarded the most money shall be
deemed the prevailing party for all purposes and shall therefore be entitled to an additional award of the full amount of the attorneys’
fees and expenses paid by such prevailing party in connection with the litigation and/or dispute without reduction or apportionment based
upon the individual claims or defenses giving rise to the fees and expenses. Nothing herein shall restrict or impair a court’s
power to award fees and expenses for frivolous or bad faith pleading.

 

5.14.
Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and
shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.

 

    8

     

    

 

5.15.
Payment Set Aside. To the extent that the (i) Company makes a payment or payments to the Buyer hereunder, pursuant to the Note,
pursuant to the Warrant, or pursuant to any other agreement, certificate, instrument or document contemplated hereby or thereby, or (ii)
the Buyer enforces or exercises its rights hereunder, pursuant to the Note, pursuant to the Warrant, or pursuant to any other agreement,
certificate, instrument or document contemplated hereby or thereby, and such payment or payments or the proceeds of such enforcement
or exercise or any part thereof (including but not limited to the sale of the Securities) are for any reason (i) subsequently invalidated,
declared to be fraudulent or preferential, set aside, recovered from, or disgorged by the Buyer, or (ii) are required to be refunded,
repaid or otherwise restored to the Company, a trustee, receiver or any other person or entity under any law (including, without limitation,
any bankruptcy law, foreign, state or federal law, common law or equitable cause of action), then (i) to the extent of any such restoration
the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such
payment had not been made or such enforcement or setoff had not occurred and (ii) the Company shall immediately pay to the Buyer a dollar
amount equal to the amount that was for any reason (i) subsequently invalidated, declared to be fraudulent or preferential, set aside,
recovered from, or disgorged by the Buyer, or (ii) required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver
or any other person or entity under any law (including, without limitation, any bankruptcy law, foreign, state or federal law, common
law or equitable cause of action).

 

5.16.
Indemnification. In consideration of the Buyer’s execution and delivery of this Agreement and acquiring the Securities hereunder,
and in addition to all of the Company’s other obligations under this Agreement, Note, or the Warrant, the Company shall defend,
protect, indemnify and hold harmless the Buyer and its stockholders, partners, members, officers, directors, employees and direct or
indirect investors and any of the foregoing persons’ agents or other representatives (including, without limitation, those retained
in connection with the transactions contemplated by this Agreement) (collectively, the “Indemnitees”) from and against
any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses in connection
therewith (irrespective of whether any such Indemnitee is a party to the action for which indemnification hereunder is sought), and including
reasonable attorneys’ fees and disbursements (the “Indemnified Liabilities”), incurred by any Indemnitee as
a result of, or arising out of, or relating to (a) any misrepresentation or breach of any representation or warranty made by the Company
in this Agreement, the Note or any other agreement, certificate, instrument or document contemplated hereby or thereby, (b) any breach
of any covenant, agreement or obligation of the Company contained in this Agreement, the Note or any other agreement, certificate, instrument
or document contemplated hereby or thereby or (c) any cause of action, suit or claim brought or made against such Indemnitee by a third
party (including for these purposes a derivative action brought on behalf of the Company) and arising out of or resulting from (i) the
execution, delivery, performance or enforcement of this Agreement, the Note or any other agreement, certificate, instrument or document
contemplated hereby or thereby, (ii) any transaction financed or to be financed in whole or in part, directly or indirectly, with the
proceeds of the issuance of the Securities, or (iii) the status of the Buyer or holder of the Securities as an investor in the Company
pursuant to the transactions contemplated by this Agreement. To the extent that the foregoing undertaking by the Company may be unenforceable
for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities
that is permissible under applicable law.

 

[Remainder
of page intentionally left blank; signature page to follow]

 

    9

     

    

 

SUBSCRIPTION
AMOUNT:

 

	Original Principal Amount of Note:	 	$	125,000	 
	Purchase Price:	 	$	112,500	 

 

IN
WITNESS WHEREOF, the undersigned Buyer and the Company have caused this Agreement to be duly executed as of the date first above written.

 

	THE
    COMPANY:	 
	Home
    Bistro, Inc.	 
	 	 	 
	By:	/s/
Zalmi Duchman	 
	 	Zalmi
    Duchman	 
	 	Chief
    Executive Officer	 
	 	 	 
	THE
    BUYER:	 
	Jefferson
    Street Capital LLC	 
	 	 	 
	By:	/s/
Brian R. Goldberg	 
	 	Brian
    R. Goldberg	 
	 	Managing
    Member	 

 

Address
for Notices:

720
Monroe Street, Suite C401B

Hoboken,
New Jersey 07030

Attention:
Brian R. Goldberg

Email:
brian@jeffersonstreetcapital.com

 

     

     

    

 

EXHIBIT
A

 

NOTE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     

     

    

 

EXHIBIT
B

 

WARRANT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}]]